G., de Groot, J
Some patients may qualify if they have: -A BMI of 35 or higher -A BMI of 30+ with conditions such as chronic kidney disease, uncontrolled high blood pressure, or heart failure -A BMI of 27+ with prediabetes, a previous heart attack, previous stroke, or symptomatic peripheral artery disease You will not be eligible if you are already receiving a GLP-1 medication through your Medicare coverage for a preexisting condition such as: -Type 2 diabetes -Moderate-to-severe sleep apnea -Certain liver conditions, including MASH Call Montgomery Medical today at 724-569-8100 or go online to schedule a consultation and see if you may qualify for the Medicare GLP-1 Bridge Program
Benefit #4: Cardiovascular Risk Reduction (Moderate Evidence) Evidence Quality: Animal studies with promising markers Mechanism: Improved lipid profile and reduced inflammation Research indicates 5-amino-1MQ may reduce cardiovascular risk through multiple pathways
Nevertheless, aerosolized GSH (Roum et al., 1999) and hypertonic saline (Gould et al., 2010) can augment airway GSH
Those are large reductions, but the context matters
Monitors status and alerts staff